Email
IZ Express #1,774: Updated COVID-19 document checklist, MenB resources with new Bexsero schedule, and more
| From | Immunize.org <[email protected]> |
| Subject | IZ Express #1,774: Updated COVID-19 document checklist, MenB resources with new Bexsero schedule, and more |
| Date | September 11, 2024 10:01 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
[link removed] [link removed] [link removed] [link removed] [link removed]
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,774: September 11, 2024
Top Stories
* “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” links you to available 2024–25 guidance documents (#IZX1)
* Immunize.org updates key MenB resources to reflect new FDA-approved Bexsero schedule (#IZX2)
* Immunize.org posts its 2024–25 update to "Influenza: Questions and Answers" (#IZX3)
* Immunize.org updates its clinician resource, "Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens," adding Vaxelis (DTaP-IPV-Hib-HepB) as a preferred Hib option for American Indian and Alaska Native infants (#IZX4)
* National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients (#IZX5)
* Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico. (#IZX6)
* “How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early”: Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube (#IZX7)
* Vaccines in the news (#IZX8)
Immunize.org Website and Clinical Resources
* Spotlight on the website: Visit our library of short educational videos (#IZX9)
* Recap: Immunize.org updates “Ask the Experts: RSV (Respiratory Syncytial Virus)” web section for the 2024–25 season (#IZX10)
* Recap: Immunize.org updates “Vaccinations for Adults: You’re Never Too Old to Get Vaccinated!” handout with current pneumococcal and RSV recommendations (#IZX11)
* Recap: Immunize.org updates the Spanish translations of 2024–25 screening checklists for contraindications to injectable and nasal influenza vaccines (#IZX12)
* Summary: These updated Immunize.org educational materials for clinicians were released during July and August (#IZX13)
Vaccine Information Statements
* Summary: These new VIS translations were posted in August (#IZX14)
Featured Resources
* Mighty handy! Immunize.org offers adult and lifetime handheld immunization record cards you can provide your patients. (#IZX15)
Upcoming Events
* Virtual: North Dakota State University hosts webinar titled “Vaccines under the Microscope: How Can We Know They Are Safe?" on September 19 and 20 at 12:00 p.m. (ET) and archived webinars; CE credit available (#IZX16)
* Virtual: WHO hosts webinar titled “Inequality in Immunization 2024” on September 24 at 7:00 a.m. (ET) (#IZX17)
* Virtual: CDC hosts webinar titled “Vaccinations for School-Age Children: An Opportunity for Health Promotion, Collaboration, and Family Engagement!” on September 25 at 3:00 p.m. (ET); CE credit available (#IZX18)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” links you to available 2024–25 guidance documents
Immunize.org reviews its Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) at least monthly, prominently indicating when it was last revised. In September, Immunize.org updated the checklist to reflect the FDA licensed/authorized 2024–25 COVID-19 mRNA vaccines (Moderna and Pfizer-BioNTech) and adjuvanted-protein vaccine (Novavax).
ACIP voted in June 2024 to recommend the use of these vaccines as licensed or authorized by FDA. Therefore, clinicians may begin using any of the 2024–25 COVID-19 vaccines as indicated by FDA as soon as they receive them.
Related CDC resources, including standing orders templates, are being updated, and Immunize.org will revise the checklist as resources become available. The out-of-date 2023–24 COVID-19 vaccine resources are highlighted on the checklist as "under revision."
[link removed]
All COVID-19 vaccine providers should regularly review this checklist. Download the latest documents and discard outdated versions.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines A–Z: COVID-19 ([link removed]) main page
* CDC: Interim Clinical Considerations ([link removed]) main page for use of COVID-19 vaccines in the United States
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates key MenB resources to reflect new FDA-approved Bexsero schedule
On August 19, FDA approved a new dosing schedule for GSK meningococcal B (MenB) vaccine ([link removed]) (Bexsero) that matches the schedule for Pfizer MenB vaccine (Trumenba). The routine 2-dose schedule requires a 6-month interval between doses. If a second dose is given earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose. Immunocompromised people and those at high risk of MenB disease should receive a 3-dose schedule with doses given at 0, 1–2, and 6-month intervals. If the second dose of a 3-dose schedule is delayed and administered 6 months or longer after the first dose, the third dose is not needed. Bexsero’s original 2-dose schedule, with a 1-month interval between the doses, is no longer licensed.
Immunize.org is updating its MenB resources to reflect the new schedule. The first updated resources include:
* Standing Orders for Administering Meningococcal B Vaccine to Adolescents and Adults ([link removed]) – several URLs were updated and sutimlimab (Enjaymo, Bioverativ Therapeutics) was added to the list of complement inhibitors. The precaution concerning latex allergy was removed because Bexsero packaging no longer contains natural latex.
* Meningococcal B Vaccine Recommendations by Age and Risk Factor ([link removed]) – This one-page reference was updated with the new Bexsero schedule
[link removed] [link removed]
ACIP is expected to review the new schedule at its October 2024 meeting. Questions about recipients of the previously approved 2-dose (1-month interval) Bexsero schedule are likely to be discussed. Until then, healthcare providers should refer to the updated Bexsero package insert for the currently approved schedule.
Related Links
* Immunize.org: Vaccines A–Z: Meningococcal B ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org posts its 2024–25 update to "Influenza: Questions and Answers"
The 2024–25 version of Immunize.org handout Influenza: Questions and Answers ([link removed]) is now available. It includes ACIP’s recommendation for the off-label option to use high-dose IIV or adjuvanted IIV (licensed for adults age 65 years or older) in adults age 18–64 who received a solid organ transplant and are on an immunosuppressive medication regimen, without preference over other age-appropriate influenza vaccine options. URLs were updated throughout the document.
[link removed]
Related Links
* Immunize.org: Influenza: Questions and Answers ([link removed]) (PDF)
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates its clinician resource, "Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens," adding Vaxelis (DTaP-IPV-Hib-HepB) as a preferred Hib option for American Indian and Alaska Native infants
Immunize.org updated its clinician resource, Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens ([link removed]) :
* Vaxelis (Merck/Sanofi), a combination DTaP-IPV-Hib-HepB vaccine, was added as a preferred option for American Indian and Alaska Native infants, in addition to PedvaxHIB (Merck)
* Precautions about latex allergy were removed because packaging is now latex-free
[link removed]
Related Links
* Immunize.org: Vaccine A–Z: Hib (Haemophilus influenzae type b) ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
National Hispanic Heritage Month ([link removed]) , observed from September 15 to October 15, celebrates the histories, cultures, and contributions of Americans whose ancestors came from Spain and elsewhere in the Americas. Immunize.org offers a variety of resources in Spanish, including translated handouts for patients and healthcare personnel ([link removed]) and Spanish-language VISs ([link removed]) .
[link removed]
Related Links
* National Hispanic Heritage ([link removed]) Month ([link removed]) website
* Immunize.org: VIS Translations: Spanish ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
¡Viva México! September 16 is the 214th anniversary of Mexico’s independence. We celebrate our neighbors by sharing select Mexican resources for vaccination information and advocacy.
Expert committees:
* Consejo Nacional de Vacunación (CONAVA) ([link removed]) , National Advisory Committee for Vaccination, counterpart to ACIP
Advocacy groups and resources:
* Asociación Mexicana de Vacunología ([link removed])
* Alianza por la Vacunación ([link removed])
[link removed]
Helpful resources:
* Boletín Epidemiológico ([link removed]) : Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información (Epidemiological Bulletin: National Epidemiological Surveillance System Unique Information System), counterpart to MMWR
* Lineamientos Generales del Programa de Vacunación Universal y Jornadas de Salud Pública 2020 ([link removed]) (General Guidelines of the Universal Vaccination Program and Public Health Conference 2020)
* Esquema Nacional de Vacunación ([link removed]) (routine vaccination schedule)
Government institutions:
* Programa Nacional de Vacunación ([link removed]) (National Vaccination Program)
* Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) ([link removed]) (Federal Commission for Protection against Health Risks), counterpart to FDA
* Vacunas Autorizadas en México Incluyendo Fichas Tecnicas ([link removed]) (Vaccines authorized in Mexico, including technical sheets)
Best wishes to all our friends delivering vaccinations to the people of Mexico!
Back to top (#Top)
------------------------------------------------------------
“How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early”: Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early ([link removed]) . The video briefly describes what to do if the second dose of the hepatitis A vaccine is given more than 4 days before the minimum interval of 6 months after the first dose.
The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT: Trying to Time Your Vaccines Just Right? There Are No Easy Answers, but Here Are Some Factors to Consider ([link removed]) (9/4/24)
* The Guardian: 'A Ton of COVID Out There’: US Summer Wave Not Taken Seriously Enough – Experts ([link removed]) (9/4/24)
* Washington Post: Coronavirus Vaccines, Once Free, Are Now Pricey for Uninsured People ([link removed]) (9/3/24)
* Healthline: Why Getting Your Flu and COVID-19 Shots at the Same Time Is a Good Idea This Year ([link removed]) (9/3/24)
* MPR News: Measles Outbreak Affects at Least 30 in Minnesota, Closes Somali Religious School ([link removed]) (9/2/24)
* NPR: Childhood Vaccination Rates and the New School Year ([link removed]) (9/2/24)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Visit our library of short educational videos
Immunize.org offers more than 60 short videos for staff education, presentations, and sharing on social media. At the “Clinical Resources” tab on the menu bar at the top of every page, select “Webinars & Videos” from the bottom of the left menu.
From the “Webinars & Videos” home page, choose the option to view available “Videos” by clicking on the folder tab.
Narrow your search by filtering videos to one of four “Subjects” (categories) available:
Orientation Video Series ([link removed] ) : These 3–4-minute videos introduce you to our organization and its mission, and guide viewers through the most popular sections of our website. Videos are available in a landscape view showing how the website looks on a desktop computer or a vertical “mobile view” that demonstrates the navigation of Immunize.org on a smartphone.
Ask the Experts Video Series ([link removed]) : These 1–3-minute videos answer diverse clinical questions taken from our popular Ask the Experts web section. These videos can also be accessed through the Ask the Experts web section.
Improving the Vaccination Experience Video Series ([link removed]) : These 3–4-minute videos provide healthcare providers and vaccine recipients or caregivers with science-based methods to reduce pain and anxiety during vaccination visits. These resources address the needs of anxious children and adults.
Partner videos ([link removed]) : These provide vaccine information from our trusted partners, such as the Vanderbilt Kennedy Center for Excellence, Vaccine Education Center of the Children’s Hospital of Philadelphia, and CDC.
Related Links
* Immunize.org Videos ([link removed]) main page
* Immunize.org Webinars ([link removed]) main page
* Immunize.org YouTube channel ([link removed])
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Ask the Experts: RSV (Respiratory Syncytial Virus)” web section for the 2024–25 season
Immunize.org updated its popular Ask the Experts: RSV (Respiratory Syncytial Virus) ([link removed]) web page to reflect the 2024 ACIP recommendations for RSV vaccination of older adults and the mRNA vaccine (mResvia, Moderna). The content now addresses the updated ACIP recommendations for older adults, including the routine recommendation for one dose of RSV vaccine for all adults age 75 years or older and the recommendation for one dose of RSV vaccine for adults age 60 through 74 who are at increased risk of severe RSV disease.
[link removed]
Immunize.org’s Ask the Experts ([link removed]) main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MPH.
Related Link
* Immunize.org: Ask the Experts ([link removed]) main page with more than 1,300 questions and answers
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Vaccinations for Adults: You’re Never Too Old to Get Vaccinated!” handout with current pneumococcal and RSV recommendations
Immunize.org updated its Vaccinations for Adults: You’re Never Too Old to Get Vaccinated! ([link removed]) This handout now includes the updated recommendations for routine RSV vaccination of adults age 75 years and older, as well as risk-based recommendations for adults age 60–74 years. Information on pneumococcal vaccines was reworded for greater clarity.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Adult Vaccination ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates the Spanish translations of 2024–25 screening checklists for contraindications to injectable and nasal influenza vaccines
Immunize.org updated its Spanish translations of screening checklists for the 2024–25 influenza season ([link removed]) .
* Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]) (view in English ([link removed]) )
* Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]) (view in English ([link removed]) )
References to the number of influenza virus strains in the vaccines were removed because all vaccines for this season contain three strains, two influenza A and one influenza B strain. The B/Yamagata strain is no longer included because it is not detected anywhere in the world.
[link removed] [link removed]
Related Links
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
* Immunize.org: Clinical Resources: Screening Checklists ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Summary: These updated Immunize.org educational materials for clinicians were released during July and August
IZ Express regularly provides readers with information about Immunize.org’s new and updated web pages, educational materials for healthcare professionals, and patient handouts. All Immunize.org clinical resources are free to distribute.
Immunize.org Materials for Clinicians
* Influenza materials and Ask the Experts section updated for the 2024–2025 season
+ Influenza Vaccine Products for the 2024–2025 Influenza Season ([link removed])
+ Standing Orders for Administering Influenza Vaccine to:
o Children and Teens ([link removed])
o Adults ([link removed])
+ Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]) , also available in Spanish ([link removed])
+ Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]) , also available in Spanish ([link removed])
+ Influenza Questions and Answers ([link removed])
+ QR Code Links to Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed]) , New!
+ Ask the Experts: Influenza ([link removed])
* Standing orders for administering:
+ Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants ([link removed])
+ Respiratory Syncytial Virus Vaccine (RSV) to Adults Age 60 Years and Older ([link removed]) , New!
+ Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) during Pregnancy ([link removed])
+ Pneumococcal Vaccines to Adults ([link removed])
* Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed])
* Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed])
* Vaccines with Diluents: How to Use Them ([link removed])
* Vaccine Handling Tips ([link removed])
* Before You Vaccinate Adults, Consider Their “H-A-L-O”! ([link removed])
* Record of Vaccine Declination ([link removed])
Immunize.org Materials for Patients
* Vaccinations for Adults: You’re Never Too Old to Get Vaccinated! ([link removed])
* Immunizations for Babies: A Guide for Parents ([link removed]) . Translations are now in 17 languages!
+ Arabic ([link removed]) , Bosnian ([link removed]) , Chinese–Simplified ([link removed]) , Dari ([link removed]) , French ([link removed]) , Haitian Creole ([link removed]) , Kinyarwanda ([link removed]) , Korean ([link removed]) , Nepali ([link removed]) , Pashto ([link removed]) , Russian ([link removed]) , Somali ([link removed]) , Spanish
([link removed]) , Swahili ([link removed]) , Turkish ([link removed]) , Vietnamese ([link removed]) , Ukrainian ([link removed])
Web Pages
* Ask the Experts:
+ Respiratory Syncytial Virus (RSV) ([link removed])
+ Pneumococcal ([link removed])
* 2024 Vaccine-Specific Requirements for States ([link removed]) with downloadable maps and data tables for 17 categories. New!
* 2024 Exemptions Permitted for State Childcare and School (K–12) Immunization Requirements ([link removed]) with downloadable map and data table. New!
* Archive (2023) of State Childcare, School, and College Immunization Requirements and Exemption Policies ([link removed])
* State Immunization Websites ([link removed]) include links to state government websites and additional information on childcare, school, or college immunization requirements
* Vaccine History Timeline ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Summary: These new VIS translations were posted in August
IZ Express regularly provides readers with information about VISs and translations of VISs. Vanderburgh County (Indiana) Health Department generously donated seven Marshallese ([link removed]) VIS translations, shown below.
* COVID-19 VIS PDF ([link removed]) (view in English ([link removed]) )
* Multi-vaccines (Your Child's First Vaccines) VIS PDF ([link removed]) (view in English ([link removed]) )
* MMR VIS PDF ([link removed]) (view in English ([link removed]) )
* MMRV VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella VIS PDF ([link removed]) (view in English ([link removed]) )
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Mighty handy! Immunize.org offers adult and lifetime handheld immunization record cards you can provide your patients.
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Adult immunization record cards ([link removed])
* Lifetime immunization record cards ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Clinical Resources: Documenting Vaccination ([link removed]) main page
* Immunize.org: Shop: Collection List ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: North Dakota State University hosts webinar titled “Vaccines under the Microscope: How Can We Know They Are Safe?" on September 19 and 20 at 1:00 p.m. (ET) and archived webinars; CE credit available
North Dakota State University's Center for Immunization Research and Education (CIRE) will host a webinar titled Vaccines under the Microscope: How Can We Know They Are Safe? ([link removed]) , 1:00–2:00 p.m. (ET) on September 19 and 20. The webinar will review U.S. vaccine safety surveillance systems and discuss how safety is prioritized during vaccine development and licensing.
Free CE will be provided for this activity.
Register for the webinar ([link removed]) .
[link removed]
CIRE now offers free access to recordings of its monthly webinars ([link removed]) on its website. Participants who watch the full recording and complete the pre- and post-training quizzes may earn free CE credit for each webinar.
Learn more about CE opportunities ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: WHO hosts webinar titled “Inequality in Immunization 2024” on September 24 at 7:00 a.m. (ET)
The World Health Organization (WHO) will hold a webinar titled Inequality in Immunization 2024 ([link removed]) at 7:00 a.m. (ET) on September 24. It will feature video contributions from the authors and editors of the Vaccines 2024 special issue on "Inequality in Immunization." The special issue emphasizes research and review articles that deepen our understanding of immunization inequalities. The table of contents for the 2024 special issue ([link removed]) appears here. The 2023 special issue ([link removed]) from that same journal is archived here.
Register for the webinar ([link removed]) .
Related Links
* WHO: Launch: 2024 Special Issue of Vaccines on 'Inequality in Immunization' ([link removed]) web page
* Special issue of Vaccines (MDPI): Inequality in Immunization 2024 ([link removed]) web page
* Vaccines (MDPI): Index of special issues ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Virtual: CDC hosts webinar titled “Vaccinations for School-Age Children: An Opportunity for Health Promotion, Collaboration, and Family Engagement!” on September 25 at 3:00 p.m. (ET); CE credit available
CDC, U.S. Department of Education, National Association of School Nurses, and Alliance for a Healthier Generation will host a webinar titled Vaccinations for School-Age Children: Opportunities for Health Promotion, Collaboration, and Family Engagement! ([link removed]) , 3:00–4:30 p.m. (ET) on September 25. This webinar will provide school and healthcare attendees with training on the latest ACIP vaccination recommendations for K-12 students, and evidence-based strategies for strengthening childhood vaccination coverage. There will also be tips for how to develop partnership opportunities and use resources to talk with families about the importance of childhood vaccination.
The training will be recorded and available on CDC TRAIN ([link removed]) for 1 year.
Continuing education credits for this activity are pending.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1,774: September 11, 2024
Top Stories
* “Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” links you to available 2024–25 guidance documents (#IZX1)
* Immunize.org updates key MenB resources to reflect new FDA-approved Bexsero schedule (#IZX2)
* Immunize.org posts its 2024–25 update to "Influenza: Questions and Answers" (#IZX3)
* Immunize.org updates its clinician resource, "Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens," adding Vaxelis (DTaP-IPV-Hib-HepB) as a preferred Hib option for American Indian and Alaska Native infants (#IZX4)
* National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients (#IZX5)
* Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico. (#IZX6)
* “How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early”: Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube (#IZX7)
* Vaccines in the news (#IZX8)
Immunize.org Website and Clinical Resources
* Spotlight on the website: Visit our library of short educational videos (#IZX9)
* Recap: Immunize.org updates “Ask the Experts: RSV (Respiratory Syncytial Virus)” web section for the 2024–25 season (#IZX10)
* Recap: Immunize.org updates “Vaccinations for Adults: You’re Never Too Old to Get Vaccinated!” handout with current pneumococcal and RSV recommendations (#IZX11)
* Recap: Immunize.org updates the Spanish translations of 2024–25 screening checklists for contraindications to injectable and nasal influenza vaccines (#IZX12)
* Summary: These updated Immunize.org educational materials for clinicians were released during July and August (#IZX13)
Vaccine Information Statements
* Summary: These new VIS translations were posted in August (#IZX14)
Featured Resources
* Mighty handy! Immunize.org offers adult and lifetime handheld immunization record cards you can provide your patients. (#IZX15)
Upcoming Events
* Virtual: North Dakota State University hosts webinar titled “Vaccines under the Microscope: How Can We Know They Are Safe?" on September 19 and 20 at 12:00 p.m. (ET) and archived webinars; CE credit available (#IZX16)
* Virtual: WHO hosts webinar titled “Inequality in Immunization 2024” on September 24 at 7:00 a.m. (ET) (#IZX17)
* Virtual: CDC hosts webinar titled “Vaccinations for School-Age Children: An Opportunity for Health Promotion, Collaboration, and Family Engagement!” on September 25 at 3:00 p.m. (ET); CE credit available (#IZX18)
Editorial Information (#Editorial)
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools” links you to available 2024–25 guidance documents
Immunize.org reviews its Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) at least monthly, prominently indicating when it was last revised. In September, Immunize.org updated the checklist to reflect the FDA licensed/authorized 2024–25 COVID-19 mRNA vaccines (Moderna and Pfizer-BioNTech) and adjuvanted-protein vaccine (Novavax).
ACIP voted in June 2024 to recommend the use of these vaccines as licensed or authorized by FDA. Therefore, clinicians may begin using any of the 2024–25 COVID-19 vaccines as indicated by FDA as soon as they receive them.
Related CDC resources, including standing orders templates, are being updated, and Immunize.org will revise the checklist as resources become available. The out-of-date 2023–24 COVID-19 vaccine resources are highlighted on the checklist as "under revision."
[link removed]
All COVID-19 vaccine providers should regularly review this checklist. Download the latest documents and discard outdated versions.
Related Links
* Immunize.org: Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed]) (PDF)
* Immunize.org: Vaccines A–Z: COVID-19 ([link removed]) main page
* CDC: Interim Clinical Considerations ([link removed]) main page for use of COVID-19 vaccines in the United States
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates key MenB resources to reflect new FDA-approved Bexsero schedule
On August 19, FDA approved a new dosing schedule for GSK meningococcal B (MenB) vaccine ([link removed]) (Bexsero) that matches the schedule for Pfizer MenB vaccine (Trumenba). The routine 2-dose schedule requires a 6-month interval between doses. If a second dose is given earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose. Immunocompromised people and those at high risk of MenB disease should receive a 3-dose schedule with doses given at 0, 1–2, and 6-month intervals. If the second dose of a 3-dose schedule is delayed and administered 6 months or longer after the first dose, the third dose is not needed. Bexsero’s original 2-dose schedule, with a 1-month interval between the doses, is no longer licensed.
Immunize.org is updating its MenB resources to reflect the new schedule. The first updated resources include:
* Standing Orders for Administering Meningococcal B Vaccine to Adolescents and Adults ([link removed]) – several URLs were updated and sutimlimab (Enjaymo, Bioverativ Therapeutics) was added to the list of complement inhibitors. The precaution concerning latex allergy was removed because Bexsero packaging no longer contains natural latex.
* Meningococcal B Vaccine Recommendations by Age and Risk Factor ([link removed]) – This one-page reference was updated with the new Bexsero schedule
[link removed] [link removed]
ACIP is expected to review the new schedule at its October 2024 meeting. Questions about recipients of the previously approved 2-dose (1-month interval) Bexsero schedule are likely to be discussed. Until then, healthcare providers should refer to the updated Bexsero package insert for the currently approved schedule.
Related Links
* Immunize.org: Vaccines A–Z: Meningococcal B ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Immunize.org posts its 2024–25 update to "Influenza: Questions and Answers"
The 2024–25 version of Immunize.org handout Influenza: Questions and Answers ([link removed]) is now available. It includes ACIP’s recommendation for the off-label option to use high-dose IIV or adjuvanted IIV (licensed for adults age 65 years or older) in adults age 18–64 who received a solid organ transplant and are on an immunosuppressive medication regimen, without preference over other age-appropriate influenza vaccine options. URLs were updated throughout the document.
[link removed]
Related Links
* Immunize.org: Influenza: Questions and Answers ([link removed]) (PDF)
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Immunize.org updates its clinician resource, "Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens," adding Vaxelis (DTaP-IPV-Hib-HepB) as a preferred Hib option for American Indian and Alaska Native infants
Immunize.org updated its clinician resource, Standing Orders for Administering Haemophilus influenzae Type B Vaccine to Children & Teens ([link removed]) :
* Vaxelis (Merck/Sanofi), a combination DTaP-IPV-Hib-HepB vaccine, was added as a preferred option for American Indian and Alaska Native infants, in addition to PedvaxHIB (Merck)
* Precautions about latex allergy were removed because packaging is now latex-free
[link removed]
Related Links
* Immunize.org: Vaccine A–Z: Hib (Haemophilus influenzae type b) ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
National Hispanic Heritage Month runs from September 15 to October 15; Immunize.org’s Spanish language resources support your Spanish-speaking patients
National Hispanic Heritage Month ([link removed]) , observed from September 15 to October 15, celebrates the histories, cultures, and contributions of Americans whose ancestors came from Spain and elsewhere in the Americas. Immunize.org offers a variety of resources in Spanish, including translated handouts for patients and healthcare personnel ([link removed]) and Spanish-language VISs ([link removed]) .
[link removed]
Related Links
* National Hispanic Heritage ([link removed]) Month ([link removed]) website
* Immunize.org: VIS Translations: Spanish ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Happy Mexican Independence Day, September 16! Here’s an orientation to vaccination information and advocacy in Mexico.
¡Viva México! September 16 is the 214th anniversary of Mexico’s independence. We celebrate our neighbors by sharing select Mexican resources for vaccination information and advocacy.
Expert committees:
* Consejo Nacional de Vacunación (CONAVA) ([link removed]) , National Advisory Committee for Vaccination, counterpart to ACIP
Advocacy groups and resources:
* Asociación Mexicana de Vacunología ([link removed])
* Alianza por la Vacunación ([link removed])
[link removed]
Helpful resources:
* Boletín Epidemiológico ([link removed]) : Sistema Nacional de Vigilancia Epidemiológica Sistema Único de Información (Epidemiological Bulletin: National Epidemiological Surveillance System Unique Information System), counterpart to MMWR
* Lineamientos Generales del Programa de Vacunación Universal y Jornadas de Salud Pública 2020 ([link removed]) (General Guidelines of the Universal Vaccination Program and Public Health Conference 2020)
* Esquema Nacional de Vacunación ([link removed]) (routine vaccination schedule)
Government institutions:
* Programa Nacional de Vacunación ([link removed]) (National Vaccination Program)
* Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) ([link removed]) (Federal Commission for Protection against Health Risks), counterpart to FDA
* Vacunas Autorizadas en México Incluyendo Fichas Tecnicas ([link removed]) (Vaccines authorized in Mexico, including technical sheets)
Best wishes to all our friends delivering vaccinations to the people of Mexico!
Back to top (#Top)
------------------------------------------------------------
“How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early”: Watch the 1-minute answer, part of the Ask the Experts Video Series on YouTube
This week, our featured episode from the Ask the Experts Video Series is How to Repeat a Second Dose of Hepatitis A Vaccine Given Too Early ([link removed]) . The video briefly describes what to do if the second dose of the hepatitis A vaccine is given more than 4 days before the minimum interval of 6 months after the first dose.
The 1-minute video is available on our YouTube channel ([link removed]) , along with our full collection of quick video answers to popular Ask the Experts ([link removed]) questions.
[link removed]
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise.
* Facebook at ImmunizeOrg ([link removed])
* Instagram at ImmunizeOrg ([link removed])
* LinkedIn at ImmunizeOrg ([link removed])
* YouTube at ImmunizeOrg ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccines in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* STAT: Trying to Time Your Vaccines Just Right? There Are No Easy Answers, but Here Are Some Factors to Consider ([link removed]) (9/4/24)
* The Guardian: 'A Ton of COVID Out There’: US Summer Wave Not Taken Seriously Enough – Experts ([link removed]) (9/4/24)
* Washington Post: Coronavirus Vaccines, Once Free, Are Now Pricey for Uninsured People ([link removed]) (9/3/24)
* Healthline: Why Getting Your Flu and COVID-19 Shots at the Same Time Is a Good Idea This Year ([link removed]) (9/3/24)
* MPR News: Measles Outbreak Affects at Least 30 in Minnesota, Closes Somali Religious School ([link removed]) (9/2/24)
* NPR: Childhood Vaccination Rates and the New School Year ([link removed]) (9/2/24)
Back to top (#Top)
------------------------------------------------------------
Immunize.org Website and Clinical Resources
------------------------------------------------------------
Spotlight on the website: Visit our library of short educational videos
Immunize.org offers more than 60 short videos for staff education, presentations, and sharing on social media. At the “Clinical Resources” tab on the menu bar at the top of every page, select “Webinars & Videos” from the bottom of the left menu.
From the “Webinars & Videos” home page, choose the option to view available “Videos” by clicking on the folder tab.
Narrow your search by filtering videos to one of four “Subjects” (categories) available:
Orientation Video Series ([link removed] ) : These 3–4-minute videos introduce you to our organization and its mission, and guide viewers through the most popular sections of our website. Videos are available in a landscape view showing how the website looks on a desktop computer or a vertical “mobile view” that demonstrates the navigation of Immunize.org on a smartphone.
Ask the Experts Video Series ([link removed]) : These 1–3-minute videos answer diverse clinical questions taken from our popular Ask the Experts web section. These videos can also be accessed through the Ask the Experts web section.
Improving the Vaccination Experience Video Series ([link removed]) : These 3–4-minute videos provide healthcare providers and vaccine recipients or caregivers with science-based methods to reduce pain and anxiety during vaccination visits. These resources address the needs of anxious children and adults.
Partner videos ([link removed]) : These provide vaccine information from our trusted partners, such as the Vanderbilt Kennedy Center for Excellence, Vaccine Education Center of the Children’s Hospital of Philadelphia, and CDC.
Related Links
* Immunize.org Videos ([link removed]) main page
* Immunize.org Webinars ([link removed]) main page
* Immunize.org YouTube channel ([link removed])
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Ask the Experts: RSV (Respiratory Syncytial Virus)” web section for the 2024–25 season
Immunize.org updated its popular Ask the Experts: RSV (Respiratory Syncytial Virus) ([link removed]) web page to reflect the 2024 ACIP recommendations for RSV vaccination of older adults and the mRNA vaccine (mResvia, Moderna). The content now addresses the updated ACIP recommendations for older adults, including the routine recommendation for one dose of RSV vaccine for all adults age 75 years or older and the recommendation for one dose of RSV vaccine for adults age 60 through 74 who are at increased risk of severe RSV disease.
[link removed]
Immunize.org’s Ask the Experts ([link removed]) main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead); Carolyn B. Bridges, MD, FACP; Iyabode Beysolow, MD, MPH; and Jane R. Zucker, MD, MPH.
Related Link
* Immunize.org: Ask the Experts ([link removed]) main page with more than 1,300 questions and answers
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates “Vaccinations for Adults: You’re Never Too Old to Get Vaccinated!” handout with current pneumococcal and RSV recommendations
Immunize.org updated its Vaccinations for Adults: You’re Never Too Old to Get Vaccinated! ([link removed]) This handout now includes the updated recommendations for routine RSV vaccination of adults age 75 years and older, as well as risk-based recommendations for adults age 60–74 years. Information on pneumococcal vaccines was reworded for greater clarity.
[link removed]
Related Links
* Immunize.org: Clinical Resources: Adult Vaccination ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Recap: Immunize.org updates the Spanish translations of 2024–25 screening checklists for contraindications to injectable and nasal influenza vaccines
Immunize.org updated its Spanish translations of screening checklists for the 2024–25 influenza season ([link removed]) .
* Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]) (view in English ([link removed]) )
* Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]) (view in English ([link removed]) )
References to the number of influenza virus strains in the vaccines were removed because all vaccines for this season contain three strains, two influenza A and one influenza B strain. The B/Yamagata strain is no longer included because it is not detected anywhere in the world.
[link removed] [link removed]
Related Links
* Immunize.org: Vaccines A–Z: Influenza ([link removed]) main page
* Immunize.org: Clinical Resources: Screening Checklists ([link removed]) main page
* Immunize.org: Clinical Resources: Spanish Translations ([link removed]) main page
* Immunize.org: Clinical Resources A–Z ([link removed]) main page, where you can filter by topic, vaccine, language, or other criteria
Back to top (#Top)
------------------------------------------------------------
Summary: These updated Immunize.org educational materials for clinicians were released during July and August
IZ Express regularly provides readers with information about Immunize.org’s new and updated web pages, educational materials for healthcare professionals, and patient handouts. All Immunize.org clinical resources are free to distribute.
Immunize.org Materials for Clinicians
* Influenza materials and Ask the Experts section updated for the 2024–2025 season
+ Influenza Vaccine Products for the 2024–2025 Influenza Season ([link removed])
+ Standing Orders for Administering Influenza Vaccine to:
o Children and Teens ([link removed])
o Adults ([link removed])
+ Screening Checklist for Contraindications to Injectable Influenza Vaccination ([link removed]) , also available in Spanish ([link removed])
+ Screening Checklist for Contraindications to Live Attenuated Intranasal Influenza Vaccination ([link removed]) , also available in Spanish ([link removed])
+ Influenza Questions and Answers ([link removed])
+ QR Code Links to Vaccine Information Statement (VIS) Translations: Influenza (Flu) Vaccine (Inactivated or Recombinant) ([link removed]) , New!
+ Ask the Experts: Influenza ([link removed])
* Standing orders for administering:
+ Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants ([link removed])
+ Respiratory Syncytial Virus Vaccine (RSV) to Adults Age 60 Years and Older ([link removed]) , New!
+ Pfizer Respiratory Syncytial Virus (RSV) Vaccine (Abrysvo) during Pregnancy ([link removed])
+ Pneumococcal Vaccines to Adults ([link removed])
* Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools ([link removed])
* Administering Vaccines: Dose, Route, Site, and Needle Size ([link removed])
* Vaccines with Diluents: How to Use Them ([link removed])
* Vaccine Handling Tips ([link removed])
* Before You Vaccinate Adults, Consider Their “H-A-L-O”! ([link removed])
* Record of Vaccine Declination ([link removed])
Immunize.org Materials for Patients
* Vaccinations for Adults: You’re Never Too Old to Get Vaccinated! ([link removed])
* Immunizations for Babies: A Guide for Parents ([link removed]) . Translations are now in 17 languages!
+ Arabic ([link removed]) , Bosnian ([link removed]) , Chinese–Simplified ([link removed]) , Dari ([link removed]) , French ([link removed]) , Haitian Creole ([link removed]) , Kinyarwanda ([link removed]) , Korean ([link removed]) , Nepali ([link removed]) , Pashto ([link removed]) , Russian ([link removed]) , Somali ([link removed]) , Spanish
([link removed]) , Swahili ([link removed]) , Turkish ([link removed]) , Vietnamese ([link removed]) , Ukrainian ([link removed])
Web Pages
* Ask the Experts:
+ Respiratory Syncytial Virus (RSV) ([link removed])
+ Pneumococcal ([link removed])
* 2024 Vaccine-Specific Requirements for States ([link removed]) with downloadable maps and data tables for 17 categories. New!
* 2024 Exemptions Permitted for State Childcare and School (K–12) Immunization Requirements ([link removed]) with downloadable map and data table. New!
* Archive (2023) of State Childcare, School, and College Immunization Requirements and Exemption Policies ([link removed])
* State Immunization Websites ([link removed]) include links to state government websites and additional information on childcare, school, or college immunization requirements
* Vaccine History Timeline ([link removed])
Back to top (#Top)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
Summary: These new VIS translations were posted in August
IZ Express regularly provides readers with information about VISs and translations of VISs. Vanderburgh County (Indiana) Health Department generously donated seven Marshallese ([link removed]) VIS translations, shown below.
* COVID-19 VIS PDF ([link removed]) (view in English ([link removed]) )
* Multi-vaccines (Your Child's First Vaccines) VIS PDF ([link removed]) (view in English ([link removed]) )
* MMR VIS PDF ([link removed]) (view in English ([link removed]) )
* MMRV VIS PDF ([link removed]) (view in English ([link removed]) )
* Meningococcal B VIS PDF ([link removed]) (view in English ([link removed]) )
* Polio VIS PDF ([link removed]) (view in English ([link removed]) )
* Varicella VIS PDF ([link removed]) (view in English ([link removed]) )
Related Links
* Immunize.org: Vaccine Information Statements ([link removed]) main page for VISs in 47 languages ([link removed])
* Immunize.org: Dates of Current Vaccine Information Statements ([link removed]) (PDF)
* CDC: What's New with VISs ([link removed]) web page
* CDC: Current VISs ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
Mighty handy! Immunize.org offers adult and lifetime handheld immunization record cards you can provide your patients.
Immunize.org's personal immunization record cards ([link removed]) , printed on rip-proof, smudge-proof, water-proof paper, are designed to last a lifetime. They fit in a wallet when folded. The record cards are for you to give to your patients as a permanent personal vaccination record and are sold in boxes of 250.
* Adult immunization record cards ([link removed])
* Lifetime immunization record cards ([link removed])
[link removed]
Make bulk purchases and receive quantity discounts. For quotes on larger quantities or customizing, or to request sample cards, call 651-647-9009 or email [email protected] (mailto:[email protected]) .
Related Links
* Immunize.org: Clinical Resources: Documenting Vaccination ([link removed]) main page
* Immunize.org: Shop: Collection List ([link removed]) web page
Back to top (#Top)
------------------------------------------------------------
Upcoming Events
------------------------------------------------------------
Virtual: North Dakota State University hosts webinar titled “Vaccines under the Microscope: How Can We Know They Are Safe?" on September 19 and 20 at 1:00 p.m. (ET) and archived webinars; CE credit available
North Dakota State University's Center for Immunization Research and Education (CIRE) will host a webinar titled Vaccines under the Microscope: How Can We Know They Are Safe? ([link removed]) , 1:00–2:00 p.m. (ET) on September 19 and 20. The webinar will review U.S. vaccine safety surveillance systems and discuss how safety is prioritized during vaccine development and licensing.
Free CE will be provided for this activity.
Register for the webinar ([link removed]) .
[link removed]
CIRE now offers free access to recordings of its monthly webinars ([link removed]) on its website. Participants who watch the full recording and complete the pre- and post-training quizzes may earn free CE credit for each webinar.
Learn more about CE opportunities ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
Virtual: WHO hosts webinar titled “Inequality in Immunization 2024” on September 24 at 7:00 a.m. (ET)
The World Health Organization (WHO) will hold a webinar titled Inequality in Immunization 2024 ([link removed]) at 7:00 a.m. (ET) on September 24. It will feature video contributions from the authors and editors of the Vaccines 2024 special issue on "Inequality in Immunization." The special issue emphasizes research and review articles that deepen our understanding of immunization inequalities. The table of contents for the 2024 special issue ([link removed]) appears here. The 2023 special issue ([link removed]) from that same journal is archived here.
Register for the webinar ([link removed]) .
Related Links
* WHO: Launch: 2024 Special Issue of Vaccines on 'Inequality in Immunization' ([link removed]) web page
* Special issue of Vaccines (MDPI): Inequality in Immunization 2024 ([link removed]) web page
* Vaccines (MDPI): Index of special issues ([link removed]) main page
Back to top (#Top)
------------------------------------------------------------
Virtual: CDC hosts webinar titled “Vaccinations for School-Age Children: An Opportunity for Health Promotion, Collaboration, and Family Engagement!” on September 25 at 3:00 p.m. (ET); CE credit available
CDC, U.S. Department of Education, National Association of School Nurses, and Alliance for a Healthier Generation will host a webinar titled Vaccinations for School-Age Children: Opportunities for Health Promotion, Collaboration, and Family Engagement! ([link removed]) , 3:00–4:30 p.m. (ET) on September 25. This webinar will provide school and healthcare attendees with training on the latest ACIP vaccination recommendations for K-12 students, and evidence-based strategies for strengthening childhood vaccination coverage. There will also be tips for how to develop partnership opportunities and use resources to talk with families about the importance of childhood vaccination.
The training will be recorded and available on CDC TRAIN ([link removed]) for 1 year.
Continuing education credits for this activity are pending.
Register for the webinar ([link removed]) .
Back to top (#Top)
------------------------------------------------------------
For more upcoming events, visit our Calendar of Events ([link removed]) .
Editorial Information
Editor-in-Chief
Kelly L. Moore, MD, MPH
Managing Editor
John D. Grabenstein, RPh, PhD
Associate Editor
Sharon G. Humiston, MD, MPH
Writer/Publication Coordinator
Taryn Chapman, MS
Courtnay Londo, MA
Style and Copy Editor
Marian Deegan, JD
Web Edition Managers
Arkady Shakhnovich
Jermaine Royes
Contributing Writer
Laurel H. Wood, MPA
Technical Reviewer
Kayla Ohlde
About IZ Express
Immunize.org welcomes redistribution of this issue of IZ Express or selected articles.
When you do so, please add a note that Immunize.org is the source of the material and provide a link to this issue ([link removed]) .
IZ Express is supported in part by Grant No. 1NH23IP922654 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer ([link removed])
ISSN: 2771-8085
This email was sent to [email protected] (mailto:[email protected])
why did I get this? ([link removed]) unsubscribe from this list ([link removed]) update subscription preferences ([link removed])
Immunize.org . 2136 Ford Parkway . Suite 5011 . Saint Paul, MN 55116 . USA
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp